Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CDKN2C Antikörper (AA 101-168) (Cy5.5)

CDKN2C Reaktivität: Human WB, IF (cc), IF (p) Wirt: Kaninchen Polyclonal Cy5.5
Produktnummer ABIN706186
  • Target Alle CDKN2C Antikörper anzeigen
    CDKN2C (Cyclin-Dependent Kinase Inhibitor 2C (p18, Inhibits CDK4) (CDKN2C))
    Bindungsspezifität
    • 14
    • 13
    • 9
    • 5
    • 2
    • 1
    • 1
    • 1
    AA 101-168
    Reaktivität
    • 58
    • 17
    • 11
    • 2
    • 1
    Human
    Wirt
    • 52
    • 6
    • 1
    Kaninchen
    Klonalität
    • 53
    • 5
    Polyklonal
    Konjugat
    • 25
    • 5
    • 5
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Dieser CDKN2C Antikörper ist konjugiert mit Cy5.5
    Applikation
    • 45
    • 23
    • 23
    • 12
    • 12
    • 10
    • 6
    • 3
    • 2
    • 1
    Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
    Homologie
    Human,Mouse,Rat,Dog,Horse
    Aufreinigung
    Purified by Protein A.
    Immunogen
    KLH conjugated synthetic peptide derived from human CDKN2C
    Isotyp
    IgG
    Top Product
    Discover our top product CDKN2C Primärantikörper
  • Applikationshinweise
    IF(IHC-P) 1:50-200
    IF(IHC-F) 1:50-200
    IF(ICC) 1:50-200
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1 μg/μL
    Buffer
    Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
    Haltbarkeit
    12 months
  • Target
    CDKN2C (Cyclin-Dependent Kinase Inhibitor 2C (p18, Inhibits CDK4) (CDKN2C))
    Andere Bezeichnung
    CDKN2C (CDKN2C Produkte)
    Synonyme
    CDKN2C antikoerper, p18 antikoerper, ink4c antikoerper, p18-ink4c antikoerper, INK4C antikoerper, p18-INK4C antikoerper, C77269 antikoerper, INK4c antikoerper, INK4d antikoerper, p18INK4c antikoerper, cyclin dependent kinase inhibitor 2C antikoerper, cyclin-dependent kinase inhibitor 2C antikoerper, cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) antikoerper, CDKN2C antikoerper, cdkn2c antikoerper, Cdkn2c antikoerper
    Hintergrund

    Synonyms: CDK6 inhibitor p18, CDKN 2C, CDKN 6, CDKN2C, CDKN6, CDN2C_HUMAN, Cyclin dependent inhibitor, Cyclin dependent kinase 4 inhibitor C, Cyclin dependent kinase 6 inhibitor, Cyclin dependent kinase 6 inhibitor p18, Cyclin dependent kinase inhibitor 2C p18 inhibits CDK4, Cyclin dependent kinase inhibitor 2C, Cyclin-dependent kinase 4 inhibitor C, Cyclin-dependent kinase 6 inhibitor, INK4C, OTTHUMP00000046546, p18, p18 inhibits CDK4, p18 INK4C, p18 INK6, p18-INK4C, p18-INK6.

    Background: p18 INK4C is a specific inhibitor of cdk4 / cdk6 (it interacts strongly with CDK6 and weakly with CDK4), and is expressed during G1 to S transition in the eukaryotic cell division cycle. It is maximally induced as cells enter S phase. Highest expression levels are found in skeletal muscle, but it is also found in the pancreas and heart.

    Gen-ID
    1031
    Pathways
    Zellzyklus, Mitotic G1-G1/S Phases
Sie sind hier:
Kundenservice